National Health Investors NHI
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
National Health Investors (NHI) Core Market Data and Business Metrics
Latest Closing Price
$74.27Price-Earnings Ratio
23.73Total Outstanding Shares
45.69 Million SharesDividend
$0.90 Per Share QuarterlySIC Description
Real Estate Investment TrustsPrimary Exchange
New York Stock ExchangeHeadquarters
222 Robert Rose Drive, Murfreesboro, TN, 37129
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-192.31 Million |
| Net Cash Flow From Financing Activities, Continuing | $-13.57 Million |
| Net Cash Flow From Operating Activities | $207.77 Million |
| Net Cash Flow From Investing Activities | $-192.31 Million |
| Net Cash Flow | $1.89 Million |
| Net Cash Flow From Operating Activities, Continuing | $207.77 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $-916,000 |
| Net Income/Loss Attributable To Noncontrolling Interest | $-1.35 Million |
| Income/Loss From Continuing Operations Before Tax | $136.64 Million |
| Benefits Costs and Expenses | $198.54 Million |
| Income/Loss From Equity Method Investments | $402,000 |
| Diluted Average Shares | $44.10 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $136.64 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $136.64 Million |
| Other Comprehensive Income/Loss | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Noncurrent Liabilities | $0 |
| Liabilities | $1.23 Billion |
| Assets | $2.61 Billion |
| Temporary Equity | $9.79 Million |
| Redeemable Noncontrolling Interest | $9.79 Million |
| Liabilities And Equity | $2.61 Billion |
Historical Dividends
Current dividend: $0.90 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 25, 2025 | May 2, 2025 | Mar 31, 2025 | $0.9 | Quarterly |
| Nov 5, 2024 | Jan 29, 2025 | Dec 31, 2024 | $0.9 | Quarterly |
| Aug 6, 2024 | Nov 1, 2024 | Sep 27, 2024 | $0.9 | Quarterly |
| May 6, 2024 | Aug 2, 2024 | Jun 28, 2024 | $0.9 | Quarterly |
| Feb 20, 2024 | May 3, 2024 | Mar 28, 2024 | $0.9 | Quarterly |
| Nov 7, 2023 | Jan 26, 2024 | Dec 29, 2023 | $0.9 | Quarterly |